Targeting tumours with novel radiopharmaceuticals
European Pharmaceutical Review
OCTOBER 19, 2023
One aspect that is extremely promising about radiopharmaceutical therapeutics is that they do not give a patient the side effects that are commonly experienced with chemotherapy. Barrett at the Center for Gamma Ray Imaging. Dr John Babich is Director, President and Chief Scientific Officer of Ratio Therapeutics.
Let's personalize your content